Home LiteratureArticle Details

PMID: 1102986 Published · ppublish English Clinical Trial Comparative Study Journal Article

Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).

The New England journal of medicine ·Vol. 293 ·No. 25 ·1975-12-18 ·Pages 1296-300

Genton E, Gent M, Hirsh J, Harker LA

Abstract

暂无摘要

MeSH Terms

Anticoagulants/therapeutic use Aspirin/administration & dosage,therapeutic use Clinical Trials as Topic Clofibrate/adverse effects,therapeutic use Dipyridamole/administration & dosage,adverse effects,therapeutic use Drug Evaluation Fibrinolytic Agents/therapeutic use Humans Hydroxychloroquine/therapeutic use Postoperative Complications/prevention & control Pulmonary Embolism/prevention & control Sulfinpyrazone/administration & dosage,adverse effects,therapeutic use Thromboembolism/prevention & control Thrombophlebitis/prevention & control Thrombosis/prevention & control

Chemicals

Anticoagulants Fibrinolytic Agents Hydroxychloroquine Dipyridamole Clofibrate Aspirin Sulfinpyrazone

Authors & Affiliations

4 authors, click to expand affiliations / ORCID

Genton E

Gent M

Hirsh J

Harker L A

Article Info

Journal

The New England journal of medicine

Abbr.

N Engl J Med

ISSN

0028-4793

DOI

10.1056/NEJM197512182932506

Published

1975-12-18

Pages

1296-300

Language

English

Region

United States

NLM ID

0255562

Subset

External Links

PubMed source DOI: 10.1056/NEJM197512182932506 View journal details

Analysis Services

Platelet-inhibiting drugs in the prevention of clinical thrombotic disease (third of three parts).

Contact

WeChat Official Account